Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03719040 · ClinicalTrials.gov registry record
Physiologic Pacing Registry
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 870
- Enrollment target
NCT03719040: Completed study, sponsored by Abbott Medical Devices.
NCT03719040 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 870 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03719040 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 870 participants
- Enrollment target
Study Summary
The Physiologic Pacing Registry is a prospective, observational, multi-center registry performed to gain a broader understanding of 1) physiologic pacing implant and follow-up workflows, including pacing and sensing measurements and 2) the clinical utility in creating a 3-dimensional electro-anatomical map of cardiac structures prior to physiologic pacing device implants based on the clinical site's routine care.
Primary Outcome
849 subjects underwent attempted implants of physiologic pacing leads. Implant success rate was based on investigator-reported outcome.
Interventions
- DEVICE Physiologic pacing device implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 870 participants |
| Start Date | 2018-11-27 |
| Est. Completion | 2021-10-07 |
What the finished NCT03719040 record still lists
NCT03719040 is an observational study that tracks outcomes without assigning an intervention. The registered 870 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Physiologic pacing device implant is the first listed.
NCT03719040 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03719040 about?
NCT03719040 is a clinical study titled "Physiologic Pacing Registry". The Physiologic Pacing Registry is a prospective, observational, multi-center registry performed to gain a broader understanding of 1) physiologic pacing implant and follow-up workflows, including pacing and sensing measurements and 2) the clinical utility in creating a 3-dimensional electro-anatomi...
What is the current status of trial NCT03719040?
This trial is currently completed. The enrollment target is 870 participants. The study started on 2018-11-27. Estimated completion is 2021-10-07.
What interventions are being tested in trial NCT03719040?
The interventions under investigation include: Physiologic pacing device implant (DEVICE).
Who is sponsoring clinical trial NCT03719040?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04097145 · 870 participants · NA
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI